Glycemic control and implant stabilization in type 2 diabetes mellitus.
Glycemic control and implant stabilization in type 2 diabetes mellitus.
复制标题
DOI：
10.1177/0022034509334203
复制
发表时间：
2009-04
影响因子：
7.6
通讯作者：
McMahan CA
中科院分区：
文献类型：
--
作者：
Oates TW;Dowell S;Robinson M;McMahan CA
Diabetes mellitus is considered a relative contraindication to implant therapy. However, the effects of glycemic level on implant integration in patients with diabetes remains poorly understood. The hypothesis of the research was that poor glycemic control is directly related to short-term impairments implant stabilization. This prospective clinical study evaluated 10 non-diabetic patients (12 implants) and 20 type 2 diabetic patients (30 implants). Glycated hemoglobin (HbA1c) levels ranged from 4.7–12.6%. Implant stability was assessed using resonance frequency analysis over 4 months following placement. Minimum stability levels were observed 2–6 weeks following placement for all 42 implants. Patients with HbA1c≥8.1% had both a greater maximum decrease in stability from baseline and required a longer time for healing as indicated by return of stability level to baseline. This study demonstrates alterations in implant stability consistent with impaired implant integration for patients with type 2 diabetes mellitus in direct relation to hyperglycemic conditions.
登录
查看更多内容
影响因子：
1.9
作者：
Lu, Bing;Preisser, John S.;Wolfson, Mark
通讯作者：
Wolfson, Mark
影响因子：
16.2
作者：
Derr, R;Garrett, E;Saudek, CD
通讯作者：
Saudek, CD
影响因子：
2
作者：
Follak, N;Klöting, I;Merk, H
通讯作者：
Merk, H
影响因子：
4.3
作者：
Meredith, N;Alleyne, D;Cawley, P
通讯作者：
Cawley, P
影响因子：
2.9
作者：
Kirk, JK;Bell, RA;Narayan, KMV
通讯作者：
Narayan, KMV